Germany's CureVac said Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, far lower than those developed by mRNA rivals BioNTech/Pfizer and Moderna.
Jul 1, 2021
0
2
How common COVID-19 is among infants may depend on the degree of the pandemic virus circulating in a community, a new study finds.
Jun 30, 2021
0
12
A stimulating environment keeps the "hippocampus"—which is the brain's memory control center—young, so to speak. Causes of this are molecular mechanisms that affect gene regulation. These current findings from studies ...
Jun 29, 2021
0
122
(HealthDay)—There was a 10.2 percent decline in pathology reports in population-based cancer registries from Georgia and Louisiana in 2020 compared with 2019, according to a study published online June 28 in the Journal ...
Jun 28, 2021
0
1
Getting a good night's rest is essential to our physical and mental health. But what behaviors lead to healthy sleep? And do those lifestyle factors change as we get older?
Jun 23, 2021
0
17
COVID vaccine surveillance efforts are a global priority, but safety monitoring for vaccines should not reflect a single population. The largest, most extensive international study of the background rates of adverse events ...
Jun 22, 2021
0
7
(HealthDay)—U.S. health experts warn there is a ticking time bomb in 11 states where 20 percent or more of seniors still haven't gotten a COVID-19 vaccine.
Jun 21, 2021
0
1
(HealthDay)—Parents need to know that COVID-19 shots are safe and effective for kids age 12 and older, an expert says.
Jun 14, 2021
0
1
(HealthDay)—From 1980 to 2017, there was improvement in survival for acute myeloid leukemia (AML) in all age groups, except for those aged ≥70 years, according to a study published in the June 15 issue of Cancer.
Jun 10, 2021
0
1
India's national government has inappropriately prioritised people for covid-19 vaccination
Jun 10, 2021
0
1
